Cardinal Health, Inc. reported impairment charges for the third quarter ended March 31, 2024. for the quarter, the company reported pre-tax goodwill impairment charge of $90 million related to the GMPD segment.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
99.08 USD | +0.39% | -0.45% | -1.71% |
05-17 | JPMorgan Adjusts Cardinal Health Price Target to $111 From $119 | MT |
05-15 | Argus Adjusts Price Target on Cardinal Health to $115 From $120 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.71% | 24.13B | |
+21.93% | 73.38B | |
+10.34% | 8.59B | |
-19.80% | 8.06B | |
+14.16% | 5.26B | |
-0.03% | 4.21B | |
+12.70% | 4.17B | |
-2.54% | 3.89B | |
+24.00% | 3.71B | |
-1.86% | 3.03B |
- Stock Market
- Equities
- CAH Stock
- News Cardinal Health, Inc.
- Cardinal Health, Inc. Reports Impairment Charges for the Third Quarter Ended March 31, 2024